{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:33:48Z","timestamp":1791394428610,"version":"4.3.3"},"reference-count":54,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T00:00:00Z","timestamp":1469577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Child Psychol Psychiatry"],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:p>There are significant controversies regarding rising antipsychotic prescription trends in children and adolescents. Many pharmacoepidemiology trend studies have been published, and interpretations of these data are helpful in explaining what is happening in prescribing practices, but not why these patterns exist. There is a lack of qualitative data in this area, and the experience of prescribing antipsychotics to children and adolescents has not been adequately researched. We conducted a qualitative study using an interpretive phenomenological analysis of physicians\u2019 experiences of antipsychotic prescribing to children and adolescents. Prescribers participated in individual interviews and a focus group. We used a staged approach for data analysis of transcriptions. In all, 11 physicians including psychiatrists and general practitioners participated in our study. We identified themes related to context, role and identity, and decision-making and filtering. Struggles with health system gaps were significant leading to the use of antipsychotics as substitutes for other treatments. Physicians prescribed antipsychotics to youth for a range of indications and had significant concerns regarding adverse effects. Our results provide knowledge regarding the prescribers\u2019 experience of antipsychotics for children and adolescents. Important gaps exist within the health system that are creating opportunities for the initiation and continued use of these agents.<\/jats:p>","DOI":"10.1177\/1359104515617518","type":"journal-article","created":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T21:20:31Z","timestamp":1448659231000},"page":"634-648","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["System struggles and substitutes: A qualitative study of general practitioner and psychiatrist experiences of prescribing antipsychotics to children and adolescents"],"prefix":"10.1177","volume":"21","author":[{"given":"Andrea L","family":"Murphy","sequence":"first","affiliation":[{"name":"College of Pharmacy, Dalhousie University, Canada"},{"name":"Department of Psychiatry, Dalhousie University, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Gardner","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Dalhousie University, Canada"},{"name":"Department of Psychiatry, Dalhousie University, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Kisely","sequence":"additional","affiliation":[{"name":"School of Population Health, University of Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charmaine A","family":"Cooke","sequence":"additional","affiliation":[{"name":"Nova Scotia Department of Health and Wellness, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley P","family":"Kutcher","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Dalhousie University, Canada"},{"name":"Sun Life Financial Chair in Adolescent Mental Health, Dalhousie University and IWK Health Centre, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Hughes","sequence":"additional","affiliation":[{"name":"School of Nursing, Dalhousie University, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,7,27]]},"reference":[{"key":"bibr1-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205700109"},{"key":"bibr2-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.56.8.904"},{"key":"bibr3-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1080\/09638230701498358"},{"key":"bibr4-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1097\/00012272-198510000-00004"},{"key":"bibr5-1359104515617518","volume-title":"Pascalian meditations","author":"Bourdieu P.","year":"2000"},{"key":"bibr6-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.211266"},{"key":"bibr7-1359104515617518","volume-title":"Abilify product monograph","author":"Bristol-Myers Squibb Canada","year":"2011"},{"key":"bibr8-1359104515617518","unstructured":"Canadian Adverse Reaction Newsletter. (2012, January). Second-generation antipsychotics and cardiometabolic adverse reactions in children and adolescents, (No. 22). Retrieved from http:\/\/www.hc-sc.gc.ca\/dhp-mps\/alt_formats\/pdf\/medeff\/bulletin\/carn-bcei_v22n1-eng.pdf"},{"key":"bibr9-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.09.006"},{"key":"bibr10-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1016\/j.ambp.2005.11.002"},{"key":"bibr11-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.158.8.753"},{"key":"bibr12-1359104515617518","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11r07064"},{"key":"bibr13-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1207\/s15430421tip3903_2"},{"key":"bibr14-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.62.7.717"},{"key":"bibr15-1359104515617518","first-page":"11","volume-title":"The NLN criteria for appraisal of baccalaureate programs: A critical hermeneutic analysis","author":"Diekelmann N.","year":"1989"},{"key":"bibr16-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1300\/J200v01n04_04"},{"key":"bibr17-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1177\/1363461509102292"},{"key":"bibr18-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.161.7.1301"},{"key":"bibr19-1359104515617518","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200730070-00002"},{"key":"bibr20-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.005482012"},{"key":"bibr21-1359104515617518","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.45.3.214"},{"key":"bibr22-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1080\/13648470.2010.493599"},{"key":"bibr23-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-42"},{"key":"bibr24-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-198"},{"key":"bibr25-1359104515617518","first-page":"61","volume":"24","author":"Murphy A. L.","year":"2015","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"key":"bibr26-1359104515617518","volume-title":"Prescription pharmaceuticals in Canada: Off-label use","author":"Ogilvie K. K.","year":"2014"},{"key":"bibr27-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2012.647"},{"key":"bibr28-1359104515617518","first-page":"124","volume":"19","author":"Panagiotopoulos C.","year":"2010","journal-title":"Journal of the Canadian Academy of Child and Adolescent Psychiatry"},{"key":"bibr29-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1097\/01.chi.0000157543.74509.c8"},{"key":"bibr30-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G203"},{"key":"bibr31-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1089\/104454602760386905"},{"key":"bibr32-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1177\/070674371205701202"},{"key":"bibr33-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-013-0426-8."},{"key":"bibr34-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1186\/1471-244X-13-261"},{"key":"bibr35-1359104515617518","doi-asserted-by":"publisher","DOI":"10.2165\/11592020-000000000-00000"},{"key":"bibr36-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0145"},{"key":"bibr37-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2011.01363.xx"},{"key":"bibr38-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2008"},{"key":"bibr39-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1177\/070674371305800608"},{"key":"bibr40-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2005.11.002"},{"key":"bibr41-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2007.03.047"},{"key":"bibr42-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-2158"},{"key":"bibr43-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2753.2007.00859.x"},{"key":"bibr44-1359104515617518","volume-title":"Interpretative phenomenological analysis: Theory, method and research","author":"Smith J. A.","year":"2009"},{"key":"bibr45-1359104515617518","first-page":"53","volume-title":"Qualitative psychology: A practical guide to research methods","author":"Smith J. A.","year":"2008"},{"key":"bibr46-1359104515617518","volume-title":"Qualitative research in nursing: Advancing the humanistic imperative","author":"Streubert H. J.","year":"2011","edition":"5"},{"key":"bibr47-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0086826"},{"key":"bibr48-1359104515617518","unstructured":"US Food and Drug Administration. (2006). FDA approves the first drug to treat irritability associated with autism, Risperdal. FDA News, P06-163. Retrieved from http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/2006\/ucm108759.htm"},{"key":"bibr49-1359104515617518","unstructured":"US Food and Drug Administration. (2007). FDA approves Risperdal for two psychiatric conditions in children and adolescents. FDA News. Retrieved from http:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/2007\/ucm108969.htm"},{"key":"bibr50-1359104515617518","volume-title":"Researching lived experience: Human science for an action sensitive pedagogy","author":"Van Manen M.","year":"1989"},{"key":"bibr51-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1186\/1753-2000-2-26"},{"key":"bibr52-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.8.1025"},{"key":"bibr53-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199802000-00010"},{"key":"bibr54-1359104515617518","doi-asserted-by":"publisher","DOI":"10.1089\/cap.1998.8.99"}],"container-title":["Clinical Child Psychology and Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1359104515617518","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1359104515617518","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1359104515617518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:19:02Z","timestamp":1777385942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1359104515617518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,27]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.1177\/1359104515617518"],"URL":"https:\/\/doi.org\/10.1177\/1359104515617518","relation":{},"ISSN":["1359-1045","1461-7021"],"issn-type":[{"value":"1359-1045","type":"print"},{"value":"1461-7021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,27]]}}}